Farnesol Protects against Cardiotoxicity Caused by Doxorubicin-Induced Stress, Inflammation, and Cell Death: An In Vivo Study in Wistar Rats
Doxorubicin (DOXO) is an antineoplastic drug that is used extensively in managing multiple cancer types. However, DOXO-induced cardiotoxicity is a limiting factor for its widespread use and considerably affects patients’ quality of life. Farnesol (FSN) is a sesquiterpene with antioxidant, anti-infla...
Main Authors: | Abdulrab Ahmed M. Alkhanjaf, Md Tanwir Athar, Zabih Ullah, Abdullah Mohammed H. Alsayhab, Ahmad Umar, Ibrahim Ahmed Shaikh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/23/8589 |
Similar Items
-
Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity
by: V. Quagliariello, et al.
Published: (2024-05-01) -
Physicochemical properties and antibiofilm activity of mineral trioxide aggregate associated with farnesol
by: Gabriela Mariana CASTRO-NÚÑEZ, et al.
Published: (2024-08-01) -
Ameliorative action of farnesol on cyclophosphamide induced toxicity in mice
by: Atefeh Araghi, et al.
Published: (2018-01-01) -
Farnesol repurposing for prevention and treatment of Acinetobacter baumannii biofilms
by: Li Tan, et al.
Published: (2024-06-01) -
Restoration of the Phenotype of Dedifferentiated Rabbit Chondrocytes by Sesquiterpene Farnesol
by: Guan-Xuan Wu, et al.
Published: (2022-01-01)